Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance (Q72992429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Effects of troglitazone on atherogenic lipoprotein phenotype in coronary patients with insulin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1 reference

S Sunayama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Y Watanabe

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Ohmura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Sawano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Shimada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Mokuno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Daida

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Yamaguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

187-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

Beyond LDL cholesterol reduction

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Relationship of LDL Size to Insulin Sensitivity in Normoglycemic Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Insulin resistance in the pathogenesis of dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Lipolytic enzymes and plasma lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900138-0

10.1016/S0021-9150(99)00138-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10487503%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference